The Role of Increasing Detection in the Rising Incidence of Prostate Cancer
JAMAPublished 15 February 1995
Arnold L. Potosky
Citations660
SJR quartileQ1
SJR score5.35
SNIP10.71
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
The recent dramatic epidemic of prostate cancer is likely the result of the increasing detection of tumors resulting from increased PSA screening, and changes in the intensity of medical surveillance is the most plausible explanation for this trend.
Abstract
The rapid diffusion of screening interventions that have the ability to detect latent asymptomatic disease leads to important concerns regarding costs and patient quality of life for men aged 65 years and older. Geographic variability in the adoption of PSA testing underscores uncertainty and disagreement about its value for reducing prostate cancer mortality. More research is required to determine the effectiveness of screening for prostate cancer.
Keywords
Medicine
CA A Cancer Journal for CliniciansCancer statistics, 1994
1,326 Citations1994C. C. Boring, T. S. Squires +2 more
New England Journal of MedicineResults of Conservative Management of Clinically Localized Prostate Cancer
955 Citations1994Gerald W. Chodak, Ronald A. Thisted +8 more
The strategy of initial conservative management and delayed hormone therapy is a reasonable choice for some men with grade 1 or 2 clinically localized prostate cancer, particularly for those who have an average life expectancy of 10 years or less.
Medical CarePotential for Cancer Related Health Services Research Using a Linked Medicare-Tumor Registry Database
706 Citations1993Arnold L. Potosky, Gerald F. Riley +3 more
A collaborative effort to link Medicare Program data with the Surveillance, Epidemiology, and End Results (SEER) Program database will permit the investigation of the contribution of various patient and health care setting factors to treatment patterns, costs, and medical outcomes.
UrologyPatient-re ported complications and follow-up treatment after radical prostatectomy
640 Citations1993Floyd J. Fowler, Michael J. Barry +4 more
Estimates of complication and follow-up treatment rates are generally higher, and almost certainly more representative for older men, than estimates previously published.
JAMAA Decision Analysis of Alternative Treatment Strategies for Clinically Localized Prostate Cancer
556 Citations1993Craig Fleming
New England Journal of MedicineGeographic Variation in the Use of Breast-Conserving Treatment for Breast Cancer
553 Citations1992Ann B. Nattinger, Mark S. Gottlieb +3 more
There is substantial geographic variation in the use of breast-conserving surgery, which cannot be explained by differences in hospital characteristics.
New England Journal of MedicineAdvances in Diagnostic Imaging and Overestimations of Disease Prevalence and the Benefits of Therapy
551 Citations1993William C. Black, H. Gilbert Welch
Over the past two decades a vast new armamentarium of diagnostic techniques has revolutionized the practice of medicine and enhanced the physician's potential for understanding disease and treating patients but also create confusion that may ultimately be harmful to patients.
New England Journal of MedicineGeographic Variation in the Treatment of Localized Breast Cancer
481 Citations1992Diana C. Farrow, William C. Hunt +1 more
JAMAHigh 10-Year Survival Rate in Patients With Early, Untreated Prostatic Cancer
467 Citations1992Jan‐Erik Johansson
The low disease-specific mortality rate, especially in patients with highly and moderately differentiated tumors, means that any local or systemic therapy intended for patients with early prostatic cancer must be evaluated in clinical trials with untreated controls for comparison.
JNCI Journal of the National Cancer InstituteCancer Incidence and Mortality Trends Among Whites in the United States, 1947–84
455 Citations1987S S Devesa, Debra T. Silverman +8 more
This study documented rising incidence and mortality rates for four cancers: lung cancer, melanoma of the skin, multiple myeloma, and non-Hodgkin's lymphomas.
JAMAAn Assessment of Radical Prostatectomy
412 Citations1993Grace L. Lu‐Yao
The sharp increase and wide geographic variation in radical prostatectomy rates make the evaluation of this surgical procedure a pressing issue and the rising rate of radical prostateCTomy among men aged 75 years and older merits special attention.
Epidemiologic ReviewsProstate Cancer: A Current Perspective
306 Citations1991Abraham M. Y. Nomura, Laurence N. Kolonel
CA A Cancer Journal for CliniciansDefining and updating the American Cancer Society guidelines for the cancer-related checkup: prostate and endometrial cancers
305 Citations1993Curtis Mettlin, Graeme Jones +3 more
Annals of Internal MedicineProstate Cancer Screening: What We Know and What We Need To Know
276 Citations1993Barnett S. Kramer, Martin L. Brown +3 more
A number of scientific and economic uncertainties exist about the wisdom of widespread implementation of the PSA assay for screening, and these uncertainties justify a definitive randomized trial to determine whether screening for prostate cancer would reduce mortality from the disease.
The LancetChanges in prostate cancer incidence and treatment in USA
252 Citations1994Grace L. Lu‐Yao, E. Robert Greenberg
Increases in rates of prostate cancer incidence and prostate surgery have occurred in the United States without clear evidence that screening and prostectomy are effective in reducing mortality, particularly among older men, who appear least likely to benefit from early detection and surgery of occult prostate cancer.
JNCI Journal of the National Cancer InstituteRise in prostatic Cancer Incidence Associated With Increased Use of Transurethral Resection
156 Citations1990Arnold L. Potosky, Larry Kessier +3 more
Analysis of mortality trends, particularly among nonwhites, and laboratory studies of the histologic nature of clinically asymptomatic tumors suggest that part of the increase in incidence rates may reflect changes in the real risk of prostatic cancer.
Urologic Clinics of North AmericaEconomics of Screening for Carcinoma of the Prostate
142 Citations1990Scott A. Optenberg, Ian M. Thompson
The authors demonstrate the importance of attempting to predict ultimate patient outcomes before implementing any health care strategy as standard by using available data, which suggest that offering a screening program to all men ages 50 to 70 would be prohibitively expensive.
Medical CareSurgical Rate Variations: Do They Reflect the Health or Socioeconomic Characteristics of the Population?
114 Citations1982Noralou P. Roos, Leslíe L. Roos
Variations in surgical rates among the elderly across 56 small rural areas are compared with variations in characteristics of the elderly population of these areas including self-reported health status, levels of disability, mental status, socioeconomic status, ethnic characteristics, etc.
Journal of Chronic DiseasesConcepts and problems in the evaluation of screening programs
78 Citations1981Philip C. Prorok, Benjamin F. Hankey +1 more
Specific screening problems addressed within this context include the uses of various definitions of age, the age at which screening is effective, and the marginal contribution of a single screening modality.
Advances in cancer researchThe Etiopathogenesis of Prostatic Cancer with Special Reference to Environmental Factors
75 Citations1988Maarten C. Bosland
An attempt is made to develop an etiological hypothesis of human prostatic carcinogenesis and to identify promising areas for future research efforts to further elucidate the etiopathogenesis of prostatic cancer in man.
PubMedManagement of clinically localized prostatic cancer. An unresolved problem.
52 Citations1993Willet F. Whitmore
Archives of Internal MedicineIncreasing Incidence of Cancer of the Prostate
48 Citations1994Ray Demers
Increased incidence of prostate cancer is likely a result of widespread use of prostate-specific antigen, and increases are most pronounced for early stage disease and among whites compared with blacks.
PubMedProstate cancer trends in Canada: rising incidence or increased detection?
41 Citations1993Isra Levy, Laurie Gibbons +3 more
The correlations between the incidence rates of prostate cancer and those of TURP suggest that increased treatment of benign prostatic disease has led to increased detection of prostate Cancer in Canada.
PubMedTrends in prostate cancer incidence and mortality in New Mexico are consistent with an increase in effective screening.
41 Citations1994Frank D. Gilliland, Thomas Becker +3 more
The increasing occurrence of prostate cancer in the United States has led to recommendations for routine prostate cancer screening in men aged 50 years and older, and trends in incidence and mortality rates are consistent with an increase in effective screening in New Mexico.
JAMAUnwanted Variations in the Rules of Practice
39 Citations1991John E. Wennberg
There are wide variations across the nation in the rules that professional review organizations (PROs) have adopted for evaluating whether physicians should be allowed to undertake a carotid endarterectomy, remove a cataract, or implant a pacemaker.
PubMedClinical practice and new technology: prostate-specific antigen (PSA).
14 Citations1992Stuart Me, Handley Ma +3 more
A project team reviewed the literature and determined that PSA did not meet GHC's criteria for screening, and a comprehensive program was developed to educate staff, facilitate practice change, measure outcomes and provide continuing feedback to physicians.